2017 annual financial data

Aptevo Therapeutics 2017 Financial results

Direct answer

Revenue was 14,658,000 USD.

Operating income was -53,949,000 USD and net income was 6,973,000 USD.
Operating cash flow was -41,573,000 USD.

Get free Aptevo Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
14,658,000 USD
Operating income
-53,949,000 USD
Net income
6,973,000 USD
Operating cash flow
-41,573,000 USD